Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis
NCT ID: NCT02085915
Last Updated: 2015-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
670 participants
INTERVENTIONAL
2014-03-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Investigators would so like to estimate the interest of the strip PeriScreen for the fast diagnosis of the ISLA at cirrhotic patients . Investigators plan to include 670 patients, what would allow to make out a will at least on ascites 2000 on about twenty centers for duration estimated of 12 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Value of the Developed Scoring Systems for Predicting Spontaneous Bacterial Peritonitis in Cirrhotic Ascites
NCT06402071
Evaluation of Lactoferrin, Procalcitonin and Aution® Urine Dipsticks for the Diagnosis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients
NCT02798939
Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin
NCT00986817
Risk Factors of Spontaneous Fungal Peritonitis in Cirrhotic Patients
NCT05117073
Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites
NCT02975726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
strip Peri Screen
strip Peri Screen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
strip Peri Screen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of ascites due to cirrhosis
* Hospitalization for a complication of cirrhosis (ascites first decompensation, gastrointestinal bleeding, encephalopathy, etc ...).
or
* Hospitalization to perform a paracentesis evacuated outpatient
* Patients on long-term antibiotic primary or secondary prophylaxis the spontaneous bacterial peritonitis and with clinical and/or biological signs that suggest spontaneous infection of ascite.
Exclusion Criteria
* chylous ascites,
* Hemorrhagic Ascites
* Biliary Ascites (straw)
* Ascites heterogeneous appearance
* Ascites not related to portal hypertension (peritoneal carcinomatosis, pancreatic ascites, tuberculosis, etc ...)
* Patient receiving imipenem IV.
* Patients on long-term antibiotic primary or secondary prophylaxis the spontaneous bacterial peritonitis without clinical and/or biological signs that suggest spontaneous infection of ascite.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Departemental Vendee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthieu SCHNEE, Dr
Role: STUDY_DIRECTOR
CHD Vendée La Roche sur Yon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Jolimont
Haine-Saint-Paul, , Belgium
CH Amiens
Amiens, , France
CHU Besançon
Besançon, , France
CHRU de Brest
Brest, , France
CH Caen
Caen, , France
CH Cholet
Cholet, , France
Hopîtal Beaujon
Clichy, , France
Hopital Laennec
Creil, , France
CH Dijon
Dijon, , France
CH Gonesse
Gonesse, , France
CHD Vendée
La Roche-sur-Yon, , France
CH Lille
Lille, , France
CHU Nice
Nice, , France
CH Orléans
Orléans, , France
CH Reims
Reims, , France
CH Rennes
Rennes, , France
CH Rouen
Rouen, , France
CH St Antoine
Saint-Antoine, , France
CH Yves Le Foll
Saint-Brieuc, , France
CH Saint-Denis - Hôpital de la Fontaine
Saint-Denis, , France
Hôpital Purpan
Toulouse, , France
CH Vannes
Vannes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHD 065-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.